|
Printable version |
From: | Nigel McCarter <n.mccarter@clear.net.nz> |
Date: | Fri, 17 Mar 2000 06:55:52 +1300 |
Is there any more growth. Yes I think so. there are several reasons a) a second set of clinical trials are almost finished, (b) approvals are being sought for marketing from the appropriate authoroties, which means that production and cash flow should begin sometime next year. (c) there are other products in the pipeline (d) the market is very large. the stock should move from being a development speculation with no real income to a company with a real product certainly within the next two years. Whilst that time frame may seem long, its not, and I expect the share price to increase steadily over that time. With regard to information, the Bulletin from last year should still be in the library, but have a look at the company web site http://www.mil.com.au/ the technical information is good quality, and the product and the processes are real, unlike some biotech and elec tech firms. !! Finally, whilst it would be very nice to have been in at 18cents, I don't have the gift of prophesy either. Nigel At 06:30 PM 3/16/00 +1300, you wrote: >Hi Nigel, >`The Speculator' in The Bulletin picked MIV at A18c, in Aug99. >At this stage I was just getting into the Aussie market, and was not >confident enough to buy in the mid 20s. I have since watched this stock >go higher and higher. >Do you think there is anymore growth in price left? >Glen. > > > Nigel McCarter Safety Management and Information Services Ltd Box 23 019 Hamilton Phone 64 7 858 2429 Fax 64 858 2689 Mobile 02 212 4901 ---------------------------------------------------------------------------- http://www.sharechat.co.nz/ New Zealand's home for market investors To remove yourself from this list, please us the form at http://www.sharechat.co.nz/forum.html.
References
|